Skip to Main Content
California State Board of Pharmacy

Authorized HIV PrEP/PEP Medications

Business and Professions Code (BPC) section 4052.02 authorizes pharmacists to initiate and furnish HIV preexposure prophylaxis (PrEP). BPC section 4052.03 authorizes pharmacists to initiate and furnish HIV postexposure prophylaxis (PEP).

BPC section 4052.02(b) defines PrEP as a fixed-dose combination of tenofovir disoproxil fumarate (TDF) (300 mg) with emtricitabine (FTC) (200 mg), or another drug or drug combination determined by the board to meet the same clinical eligibility recommendations provided in CDC Guidelines.

BPC section 4052.03(b) defines PEP as:

(1) Tenofovir disoproxil fumarate (TDF) (300 mg) with emtricitabine (FTC) (200 mg), taken once daily, in combination with either raltegravir (400 mg), taken twice daily, or dolutegravir (50 mg), taken once daily.
(2) Tenofovir disoproxil fumarate (TDF) (300 mg) and emtricitabine (FTC) (200 mg), taken once daily, in combination with darunavir (800 mg) and ritonavir (100 mg), taken once daily.
(3) Another drug or drug combination determined by the board to meet the same clinical eligibility recommendations provided in CDC guidelines.

On September 17, 2020, the Board of Pharmacy approved the following additional drug combinations:

Training for Furnishing HIV Preexposure and Postexposure Prophylaxis (PrEP/PEP)

The Board of Pharmacy has created a free training webinar pharmacists may complete to independently initiate and furnish HIV pre-exposure and post-exposure prophylaxis, pursuant to California Code of Regulations, title 16, section 1747. Pharmacists who successfully complete the training also will receive 1.5 hours of continuing education (CE) credit.

The webinar is about 90 minutes in length, including a training presentation followed by an assessment section with 10 multiple-choice questions. In addition, the presenter has provided a list of abbreviations used in the webinar training program. Participants must view the entire 90-minute webinar and obtain a passing score on the assessment to receive a certificate of successful completion and CE credit.

Note: Please allow enough time to complete the entire training program in one session to receive credit for viewing the entire webinar. Because of technical limitations, credit cannot be given for viewing the entire 90-minute training program in multiple discrete sections.

Pursuant to CCR section 1747(a)(2), participants must obtain a passing score of 70 percent or higher to receive a certificate of successful completion of the training program. Participants who do not obtain a passing score will not receive a certificate of completion nor CE credit.

Tips for Viewing the Webinar

To begin the video:

Training Webinar: HIV Pre-Exposure and Post-Exposure Prophylaxis for California Pharmacists